A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors

Jens Voortman, Egbert F. Smit, Richard Honeywell, Bart C. Kuenen, Godefridus J. Peters, Helgi van de Velde, Giuseppe Giaccone

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3642-3651
JournalClinical Cancer Research
Issue number12
Publication statusPublished - 15 Jun 2007

Cite this